Delivery Order SPE2DB22D2007-SPE2DB25FJ5JJ
- Not listed
- The Defense Logistics Agency awarded a $1,190.29 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. This is a non-set-aside competitive award with an ultimate completion date of August 27, 2025, and performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,708.86 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. This firm fixed price delivery order, awarded on August 8, 2025, is set to be completed by August 11, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, demonstrating AmerisourceBergen's capability to fulfill...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ML units, with a ceiling value of $1,310.70. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,434.04 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ml quantities. This firm fixed-price contract, with an ultimate completion date of August 25, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified pharmaceutical vendors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5mL quantities, valued at $2,587.17. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,181.65 delivery order to AmerisourceBergen Drug Corp for Olopatadine HCL 0.1% eye drops (5ml) on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Olopatadine HCL 0.1% eye drops (5ml) with a ceiling value of $3,491.87. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,380.55 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops (5 mL units). This firm fixed price, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract represents a non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Olopatadine HCL 0.1% eye drops (5 mL units) with a ceiling value of $1,148.94. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be...
- The Defense Logistics Agency awarded a Delivery Order contract valued at $2,228.42 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5JJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,046.81 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ml quantities. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award reflects AmerisourceBergen Drug Corp's established capability to meet federal procurement requirements through competitive contracting and its significant role in the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/25/25 |